Treace Medical Concepts (TMCI) Payables (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Payables for 7 consecutive years, with $19.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables fell 8.74% year-over-year to $19.2 million; the trailing twelve-month figure through Jun 2026 stood at $19.2 million (down 8.74% YoY), and the FY2025 full-year result was $8.5 million, down 19.49% from the prior year.
• Payables advanced to $19.2 million in Q2 2026 per TMCI's latest filing, from $15.3 million in the prior quarter.
• Across five years, Payables topped out at $21.1 million in Q1 2024 and bottomed at $3.1 million in Q2 2022.
• Historically, Payables has averaged $12.2 million across 5 years, with a median of $11.2 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Payables surged 316.65% in 2024, then slumped 37.26% in 2025.
• Over 5 years, Payables stood at $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then declined by 11.09% to $10.5 million in 2024, then decreased by 19.49% to $8.5 million in 2025, then jumped by 127.01% to $19.2 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $19.2 million, $15.3 million, and $8.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.